Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Endocrine-Related Cancer|May 4, 2023
Identification of long noncoding RNAs with aberrant expression in prostate cancer metastasesMina Sattari, Annika Kohvakka, Elaheh Moradi, et al.The Prostate|January 15, 2009
Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cellsJ Kellogg Parsons, Elizabeth A Saria, Masashi Nakayama, et al.Scientific Reports|September 24, 2021
Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumorsQing Kay Li, Jing Chen, Yingwei Hu, et al.Cancer Research|November 1, 2008
DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneitySrinivasan Yegnasubramanian, Michael C Haffner, Yonggang Zhang, et al.Science Translational Medicine|January 25, 2013
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastasesMartin J Aryee, Wennuan Liu, Julia C Engelmann, et al.Nature Genetics|July 6, 2010
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangementsMichael C Haffner, Martin J Aryee, Antoun Toubaji, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 3, 2013
Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancerKatri A Leinonen, Outi R Saramäki, Bungo Furusato, et al.Epigenetics|September 28, 2011
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancerJacob Schwartzman, Solange Mongoue-Tchokote, Angela Gibbs, et al.Human Mutation|May 3, 2013
Somatic alterations contributing to metastasis of a castration-resistant prostate cancerMichael L Nickerson, Kate M Im, Kevin J Misner, et al.Nature Medicine|April 14, 2009
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancerWennuan Liu, Sari Laitinen, Sofia Khan, et al.Pageof 7